Relapsed/Refractory AML
Oncology·MeSH: Leukemia, Myeloid, Acute
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| uproleselan | Apollomics Inc. (APLM) |
Compare drugs
Frequently asked questions
How many drugs are in development for Relapsed/Refractory AML?
BioSniper tracks 3 drugs in development for Relapsed/Refractory AML across 3 companies.
How many clinical trials target Relapsed/Refractory AML?
There are 2 clinical trials targeting Relapsed/Refractory AML tracked by BioSniper.
Deep-dive into Relapsed/Refractory AML
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis